<DOC>
	<DOCNO>NCT00532935</DOCNO>
	<brief_summary>A study evaluate efficacy safety MK0431A comparison commonly use medication patient type 2 diabetes</brief_summary>
	<brief_title>MK0431A vs. Pioglitazone Patients With Type 2 Diabetes Mellitus ( 0431A-066 )</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Pioglitazone</mesh_term>
	<mesh_term>Metformin</mesh_term>
	<mesh_term>Sitagliptin Phosphate</mesh_term>
	<criteria>General Patient type 2 diabetes mellitus Patient inadequately control treatment insulin oral antihyperglycemic therapy General Patient history type 1 diabetes mellitus history ketoacidosis Patient antihyperglycemic agent therapy ( oral insulin ) within prior 12 week Patient &gt; 4 week ( cumulatively ) antihyperglycemic therapy ( oral insulin ) prior 3 year</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>78 Years</maximum_age>
	<verification_date>December 2015</verification_date>
</DOC>